Inventor · disambiguated record
Alex M. Nadzan
Also filed as: NADZAN ALEX · NADZAN ALEX M · NADZAN ALEX MICHAEL · TADANIER JOHN S
24 granted patents·4 pending applications·498 citations·filing 1979–2010
96Inventor score
Top patents by PatentIndex Score
28 records- 0195US5780676ACompounds having selective activity for Retinoid X Receptors, and means for modulation of processes mediated by Retinoid X ReceptorsLIGAND PHARM INC·Filed 1995·Granted Jul 14, 1998·81 cites·23 claims
- 0289US5721103ATrienoic retinoid compounds and methodsLIGAND PHARM INC·Filed 1995·Granted Feb 24, 1998·35 cites·39 claims
- 0388US5770378ATricyclic retinoids, methods for their production and useLIGAND PHARM INC·Filed 1995·Granted Jun 23, 1998·45 cites·39 claims
- 0486US6218430B1Vitamin D3 mimicsLIGAND PHARM INC·Filed 1998·Granted Apr 17, 2001·84 cites·38 claims
- 0585US5770382ATricyclic retinoids, methods for their production and useLIGAND PHARM INC·Filed 1995·Granted Jun 23, 1998·40 cites·39 claims
- 0684US5128346ADerivatives of D-glutamic acid and D-aspartic acidABBOTT LAB·Filed 1990·Granted Jul 7, 1992·32 cites·9 claims
- 0781US6083977ATrienoic retinoid compounds and methodsLIGAND PHARM INC·Filed 1995·Granted Jul 4, 2000·20 cites·37 claims
- 0877US5340802APeptide analog type-B CCK receptor ligandsABBOTT LAB·Filed 1993·Granted Aug 23, 1994·47 cites·11 claims
- 0974US4971978ADerivatives of D-glutamic acid and D-aspartic acidNADZAN ALEX M·Filed 1988·Granted Nov 20, 1990·14 cites·8 claims
- 1072US5770383ATricyclic retinoids, methods for their production and useLIGAND PHARM INC·Filed 1995·Granted Jun 23, 1998·18 cites·39 claims
- 1172US4250304A2-Deoxy-2-substituted fortimicin A and B and derivativesABBOTT LAB·Filed 1979·Granted Feb 10, 1981·11 cites·10 claims
- 1269US7385063B2Method for preparing imidazole derivativesCHUGAI PHARMACEUTICAL CO LTD·Filed 2002·Granted Jun 10, 2008·5 cites·12 claims
- 1366US7524969B2Malonyl-CoA decarboxylase inhibitors useful as metabolic modulatorsCHUGAI PHARMACEUTICAL CO LTD·Filed 2002·Granted Apr 28, 2009·3 cites·5 claims
- 1466US6545049B1Dimer-selective RXR modulators and methods for their useLIGAND PHARM INC·Filed 1999·Granted Apr 8, 2003·22 cites·36 claims
- 1565US6610883B1Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptorsLIGAND PHARM INC·Filed 1998·Granted Aug 26, 2003·9 cites·17 claims
- 1663US5270302ADerivatives of tetrapeptides as CCK agonistsABBOTT LAB·Filed 1991·Granted Dec 14, 1993·23 cites·10 claims
- 1755US8119819B2Malonyl-CoA decarboxylase inhibitors useful as metabolic modulatorsARRHENIUS THOMAS·Filed 2009·Granted Feb 21, 2012·0 cites·4 claims
- 1854US2008070869A1Malonyl-CoA Decarboxylase Inhibitors Useful as Metabolic ModulatorsCHUGAI PHARMACEUTICAL CO LTD·Filed 2007·Application pending·0 cites
- 1952US7786145B2Cyanoguanidine-based azole compounds useful as malonyl-CoA decarboxylase inhibitorsCHUGAI PHARMACEUTICAL CO LTD·Filed 2004·Granted Aug 31, 2010·0 cites·3 claims
- 2050US7709510B2Azoles as malonyl-CoA decarboxylase inhibitors useful as metabolic modulatorsCHUGAI PHARMACEUTICAL CO LTD·Filed 2002·Granted May 4, 2010·0 cites·8 claims
- 2147US7279477B2Malonyl-CoA decarboxylase inhibitors useful as metabolic modulatorsCHUGAI PHARMACEUTICAL CO LTD·Filed 2002·Granted Oct 9, 2007·0 cites·14 claims
- 2247US4572907AHigh caloric product for I.V. administrationABBOTT LAB·Filed 1984·Granted Feb 25, 1986·4 cites·26 claims
- 2346US2004019072A1Dimer-selective RXR modulators and methods for their useFiled 2003·Application pending·0 cites
- 2444US4220756AMethod of producing 3-O-demethylfortimicin B,4-N-alkylfortimicin B derivatives and related aminoglycoside antibioticsABBOTT LAB·Filed 1979·Granted Sep 2, 1980·3 cites·6 claims
- 2540US8110686B2Azoles as malonyl-CoA decarboxylase inhibitors useful as metabolic modulatorsARRHENIUS THOMAS·Filed 2010·Granted Feb 7, 2012·0 cites·4 claims
- 2638US2005113514A14-N-acyl-delta 5-2-oxopiperazines, a process for its preparation and combinatorial libraries thereofFiled 2001·Application pending·0 cites
- 2737US2004110757A1Flt-1 ligands and their uses in the treatment of diseases regulatable by angiogenesisFiled 2002·Application pending·0 cites
- 2833US4432985AN-alkylated carboxylic acid derivatives as anti-convulsant agentsABBOTT LAB·Filed 1982·Granted Feb 21, 1984·2 cites·15 claims
Join the waitlist — get patent alerts
Get an alert when Alex M. Nadzan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →